EVFM — Evofem Biosciences Share News
0.000.00%
Last trade - 00:00- $0.83m
- $59.92m
- $20.18m
Brief: Evofem Reaches Agreement With One Of The Largest Pharmacy Benefit Managers In The U.S. For Access To Phexxi
U.S. STOCKS ON THE MOVE-Virgin Orbit, ETSY, Coinbase, Peloton
U.S. STOCKS ON THE MOVE-Robinhood, Spirit Airlines, Polestar, Axsome Therapeutics
U.S. STOCKS ON THE MOVE-Digital World Acquisition, Polestar, Chinese ADRs
Evofem rises after Supreme Court overturns Roe V Wade
Brief: Phexxi Prevents 99% Of Pregnancies Per Act Of Intercourse In Post HOC Analysis Of Phase 3 Ampower Clinical Trial Data
Brief: Evofem - On June 8, Co Received Notice From Nasdaq That Co Would Be Permitted To Continue Listing On Nasdaq Through Aug 22 To Regain Compliance
Brief: US Food And Drug Administration Extends Phexxi Shelf Life To Four Years
U.S. STOCKS ON THE MOVE-Immix Biopharma, Apple Inc, Chimerix Inc
U.S. STOCKS ON THE MOVE-Wix.com Ltd, VF Corp, Evofem Biosciences
Evofem Biosciences hits record low on $26.6 mln equity offering
Brief: Evofem Biosciences, Seven Knots Elect To Terminate Equity Line Deal
Brief: Evofem Biosciences Announces Pricing Of About $26.6 Million Public Offering
Brief: Evofem Biosciences Announces Proposed Public Offering
Brief: Evofem Biosciences To Decrease Cost Of Goods 45 Percent Through New Partnership With Bora Pharmaceutical Services For The Commercial Manufacturing Of Phexxi®
Brief: Evofem Presents Data Detailing Fewer Urinary Tract Infections In Women Using Phexxi
Brief: Evofem Biosciences Announces 1-For-15 Reverse Stock Split
Brief: Evofem Biosciences Reports First Quarter 2022 Financial Results And Provides Corporate Update
Evofem Biosciences Inc expected to post a loss of 21 cents a share - Earnings Preview